Designing Lead Optimisation of MMP-12 Inhibitors
The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Computational and Mathematical Methods in Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/258627 |
id |
doaj-2594c927d2114712a7bc5048d9bc2e12 |
---|---|
record_format |
Article |
spelling |
doaj-2594c927d2114712a7bc5048d9bc2e122020-11-24T23:46:43ZengHindawi LimitedComputational and Mathematical Methods in Medicine1748-670X1748-67182014-01-01201410.1155/2014/258627258627Designing Lead Optimisation of MMP-12 InhibitorsMatteo Borrotti0Davide De March1Debora Slanzi2Irene Poli3European Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyThe design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation.http://dx.doi.org/10.1155/2014/258627 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Matteo Borrotti Davide De March Debora Slanzi Irene Poli |
spellingShingle |
Matteo Borrotti Davide De March Debora Slanzi Irene Poli Designing Lead Optimisation of MMP-12 Inhibitors Computational and Mathematical Methods in Medicine |
author_facet |
Matteo Borrotti Davide De March Debora Slanzi Irene Poli |
author_sort |
Matteo Borrotti |
title |
Designing Lead Optimisation of MMP-12 Inhibitors |
title_short |
Designing Lead Optimisation of MMP-12 Inhibitors |
title_full |
Designing Lead Optimisation of MMP-12 Inhibitors |
title_fullStr |
Designing Lead Optimisation of MMP-12 Inhibitors |
title_full_unstemmed |
Designing Lead Optimisation of MMP-12 Inhibitors |
title_sort |
designing lead optimisation of mmp-12 inhibitors |
publisher |
Hindawi Limited |
series |
Computational and Mathematical Methods in Medicine |
issn |
1748-670X 1748-6718 |
publishDate |
2014-01-01 |
description |
The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation. |
url |
http://dx.doi.org/10.1155/2014/258627 |
work_keys_str_mv |
AT matteoborrotti designingleadoptimisationofmmp12inhibitors AT davidedemarch designingleadoptimisationofmmp12inhibitors AT deboraslanzi designingleadoptimisationofmmp12inhibitors AT irenepoli designingleadoptimisationofmmp12inhibitors |
_version_ |
1725492548040916992 |